» Articles » PMID: 34209249

Machine Learning Protocols in Early Cancer Detection Based on Liquid Biopsy: A Survey

Overview
Journal Life (Basel)
Specialty Biology
Date 2021 Jul 2
PMID 34209249
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

With the advances of liquid biopsy technology, there is increasing evidence that body fluid such as blood, urine, and saliva could harbor the potential biomarkers associated with tumor origin. Traditional correlation analysis methods are no longer sufficient to capture the high-resolution complex relationships between biomarkers and cancer subtype heterogeneity. To address the challenge, researchers proposed machine learning techniques with liquid biopsy data to explore the essence of tumor origin together. In this survey, we review the machine learning protocols and provide corresponding code demos for the approaches mentioned. We discuss algorithmic principles and frameworks extensively developed to reveal cancer mechanisms and consider the future prospects in biomarker exploration and cancer diagnostics.

Citing Articles

Unveiling the impact of corticosteroid therapy on liquid biopsy-detected cell-free DNA levels in meningioma and glioblastoma patients.

Aran V, de Melo Junior J, Pilotto Heming C, Zeitune D, Moura Neto V, Niemeyer Filho P J Liq Biopsy. 2025; 5:100149.

PMID: 40027945 PMC: 11863984. DOI: 10.1016/j.jlb.2024.100149.


Liquid biopsy into the clinics: Current evidence and future perspectives.

Boukovala M, Westphalen C, Probst V J Liq Biopsy. 2025; 4:100146.

PMID: 40027149 PMC: 11863819. DOI: 10.1016/j.jlb.2024.100146.


AutoCancer as an automated multimodal framework for early cancer detection.

Liu L, Xiong Y, Zheng Z, Huang L, Song J, Lin Q iScience. 2024; 27(7):110183.

PMID: 38989460 PMC: 11233972. DOI: 10.1016/j.isci.2024.110183.


Constructing diagnostic signature of serum microRNAs using machine learning for early pan-cancer detection.

Xu Y, Liao W, Chen H, Pan M Discov Oncol. 2024; 15(1):263.

PMID: 38965104 PMC: 11224052. DOI: 10.1007/s12672-024-01139-1.


The Circulating Biomarkers League: Combining miRNAs with Cell-Free DNAs and Proteins.

Felekkis K, Papaneophytou C Int J Mol Sci. 2024; 25(6).

PMID: 38542382 PMC: 10969827. DOI: 10.3390/ijms25063403.


References
1.
Cucchiara F, Del Re M, Valleggi S, Romei C, Petrini I, Lucchesi M . Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer. Front Oncol. 2021; 10:593831. PMC: 7819134. DOI: 10.3389/fonc.2020.593831. View

2.
Diaz-Uriarte R, de Andres S . Gene selection and classification of microarray data using random forest. BMC Bioinformatics. 2006; 7:3. PMC: 1363357. DOI: 10.1186/1471-2105-7-3. View

3.
Raman L, Van der Linden M, Van der Eecken K, Vermaelen K, Demedts I, Surmont V . Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma. Genome Med. 2020; 12(1):35. PMC: 7175544. DOI: 10.1186/s13073-020-00735-4. View

4.
Best M, Sol N, In t Veld S, Vancura A, Muller M, Niemeijer A . Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets. Cancer Cell. 2017; 32(2):238-252.e9. PMC: 6381325. DOI: 10.1016/j.ccell.2017.07.004. View

5.
Heitzer E, Perakis S, Geigl J, Speicher M . The potential of liquid biopsies for the early detection of cancer. NPJ Precis Oncol. 2018; 1(1):36. PMC: 5871864. DOI: 10.1038/s41698-017-0039-5. View